AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildaniz MF 50/500Mg Tablet

Prescription Icon
Prescription Required

Marketer

Barter & Marcin Pharma

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildaniz MF 50/500Mg Tablet

Metformin-glimepiride 50/500mg tablets manage elevated blood glucose in type 2 diabetes patients. This dual-action medication mitigates severe diabetic complications like nephropathy and retinopathy, potentially lowering cardiovascular event risk. Prescribed independently or adjunctively with other antidiabetic agents, optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concurrent medications. Consuming it with meals minimizes gastrointestinal distress. Consistent daily dosing ensures maximum therapeutic benefit; discontinuation should only occur under medical guidance. Effective blood sugar regulation prevents future complications. Continued commitment to your doctor's prescribed diet and exercise regimen is crucial for successful diabetes management, as lifestyle significantly impacts glycemic control. Common adverse effects may encompass diarrhea, nausea, emesis, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, particularly with concomitant insulin or sulfonylurea use; learn hypoglycemia recognition and management. This medication isn't universally suitable. Inform your physician of prior renal, hepatic, or cardiac conditions, pancreatic disorders, or excessive alcohol consumption before commencing treatment. Pregnant or lactating individuals should seek medical counsel. Drug interactions are possible; disclose all medications to your doctor to ensure treatment safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout therapy.

Primary Ingredients of Vildaniz MF 50/500Mg Tablet

No text provided to rephrase.

Uses of Vildaniz MF 50/500Mg Tablet

Managing Type 2 diabetes

Major Benefits of Vildaniz MF 50/500Mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vildaniz MF 50/500Mg Tablets should be administered with a meal.

Common Side effects of Vildaniz MF 50/500Mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildaniz MF 50/500Mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Vildaniz MF 50/500Mg Tablet with food.

How Vildaniz MF 50/500Mg Tablet works:

Vildaniz MF 50/500 mg tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildaniz MF 50/500Mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildaniz MF 50/500Mg Tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildaniz MF 50/500Mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildaniz MF 50/500 mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Vildaniz MF 50/500Mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildaniz MF 50/500Mg Tablet :

Should you forget a Vildaniz MF 50/500Mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildaniz MF 50/500Mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildaniz MF 50/500Mg Tablet

Vildaniz MF 50/500Mg Tablets rarely cause hypoglycemia (low blood sugar) by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Vildaniz MF 50/500Mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take additional medication without your doctor's approval.
Vildaniz MF 50/500Mg Tablets are contraindicated in patients with allergies to any ingredient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildaniz MF 50/500mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildaniz MF 50/500Mg Tablets can cause lactic acidosis, a serious, albeit rare, medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Prolonged use of Vildaniz MF 50/500Mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildaniz MF 50/500Mg Tablets are safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you're also taking insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Vildaniz MF 50/500Mg Tabl...
168
MRP 195
13% off